|
GNG5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.64070037742692E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.05869979449835E-10 |
| Normal-vs-Stage2 |
7.61710000000138E-05 |
| Normal-vs-Stage3 |
2.29509999893907E-09 |
| Normal-vs-Stage4 |
6.080400E-03 |
| Stage1-vs-Stage2 |
5.976600E-01 |
| Stage1-vs-Stage3 |
7.548400E-01 |
| Stage1-vs-Stage4 |
2.118600E-03 |
| Stage2-vs-Stage3 |
7.904800E-01 |
| Stage2-vs-Stage4 |
1.082190E-01 |
| Stage3-vs-Stage4 |
1.264290E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.44969949775498E-10 |
| Normal-vs-AfricanAmerican |
1.104360E-03 |
| Normal-vs-Asian |
1.368370E-01 |
| Caucasian-vs-AfricanAmerican |
7.450200E-02 |
| Caucasian-vs-Asian |
5.304600E-01 |
| AfricanAmerican-vs-Asian |
9.649600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.65450011866153E-10 |
| Normal-vs-Female |
5.96220000037562E-07 |
| Male-vs-Female |
4.118200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.227700E-02 |
| Normal-vs-Age(41-60Yrs) |
3.13939999552204E-08 |
| Normal-vs-Age(61-80Yrs) |
2.21810003697698E-09 |
| Normal-vs-Age(81-100Yrs) |
3.82410000000499E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.347000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.330200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.367790E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.586400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.192800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.771800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.717630E-02 |
| Normal-vs-Grade 2 |
7.3359999963607E-08 |
| Normal-vs-Grade 3 |
2.7627899967797E-12 |
| Normal-vs-Grade 4 |
1.939520E-02 |
| Grade 1-vs-Grade 2 |
8.211400E-01 |
| Grade 1-vs-Grade 3 |
3.209000E-01 |
| Grade 1-vs-Grade 4 |
4.153800E-01 |
| Grade 2-vs-Grade 3 |
4.988400E-02 |
| Grade 2-vs-Grade 4 |
2.022100E-02 |
| Grade 3-vs-Grade 4 |
6.802900E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.69009251038688E-12 |
| Normal-vs-ccB subtype |
4.21119999982622E-07 |
| ccA subtype-vs-ccB subtype |
1.847800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.02049998954124E-09 |
| Normal-vs-N1 |
1.460050E-01 |
| N0-vs-N1 |
1.066190E-01 |
|
|
